Targeting Oncogenic HER2 Mutations by Neratinib-induced HER2 Ubiquitination and Degradation in Breast Cancer.

Nerlynx (neratinib) - Puma

http://www.ncbi.nlm.nih.gov/pubmed/42517404

Dian Yang; Han Liu; Jiayu Li; Jie Hu; Jinrui Zhang; Shaoxuan Cheng; Shuyan Liu; Xin Su; Xuesong Meng; Yingqiu Zhang; Yue Zhu; Yueshun Hong

Jul 29, 2026